Frequently Asked Questions
Preclinical Ophthalmology
Choosing a preclinical ophthalmology CRO involves more than comparing services. It requires finding a partner with the scientific expertise, technical capabilities, and integrated workflows needed to generate reliable, translational data.
These FAQs answer common questions about non-GLP ophthalmology studies, animal models, imaging technologies, and CRO selection to help you make informed outsourcing decisions.
1. How Do I Choose the Right Preclinical Ophthalmology CRO?
Ophthalmology studies require specialized surgical techniques, disease induction methods, imaging platforms, and endpoint interpretation that differ substantially from other therapeutic areas. Small differences in injection technique, imaging quality, or ocular examination can significantly affect study variability and data interpretation.
Powered Research is dedicated to ophthalmology and performs all ophthalmic examinations under the guidance of a board-certified veterinary ophthalmologist. Combined with advanced ocular imaging, functional testing, and disease-specific expertise, this enables generation of highly reproducible, translational datasets that better support candidate selection and development decisions.
2. What Makes a Non-GLP Ophthalmology Study Translational?
A translational study should do more than demonstrate statistical significance—it should reproduce clinically relevant disease biology using endpoints that are predictive of patient outcomes.
This requires selecting the appropriate disease model, animal species, route of administration, dosing paradigm, imaging modalities, and histological endpoints for the therapeutic mechanism being evaluated.
Powered Research integrates in-life procedures, multimodal imaging, pharmacokinetics, histology, and quantitative pathology within a single scientific team, helping sponsors generate comprehensive datasets that support informed go/no-go decisions before GLP studies and clinical development.
3. Should My Ophthalmology CRO Perform All Study Activities In-House?
Many preclinical programs involve multiple vendors for animal work, imaging, histology, and tissue analysis. Every transfer introduces scheduling delays, sample handling risks, communication challenges, and potential variability.
Powered Research performs breeding, animal husbandry, ocular dosing, imaging, tissue collection, histology, and endpoint analyses at a single facility by the same scientific team. This integrated workflow minimizes logistical complexity while improving study consistency, data integrity, and turnaround times.
4. How Do I Select the Best Animal Model for an Ophthalmology Drug?
Model selection begins with the therapeutic hypothesis rather than the disease name alone.
Key considerations include:
• therapeutic modality (small molecule, biologic, gene therapy, cell therapy, device)
• mechanism of action
• target tissue
• route of administration
• desired clinical indication
• primary efficacy endpoints
• regulatory development strategy
Powered Research offers validated models spanning wet AMD, dry AMD, diabetic retinopathy, glaucoma, retinal degeneration, corneal disease, ocular inflammation, and uveitis across multiple species. Custom models can also be developed when existing models do not adequately address a sponsor's scientific objectives.
5. What Are the Most Important Endpoints in Preclinical Ophthalmology Studies?
No single endpoint fully characterizes therapeutic efficacy.
Robust ophthalmology studies typically combine structural, functional, and histological assessments, including:
• Optical Coherence Tomography (OCT)
• fluorescein angiography
• fundus imaging
• electroretinography (ERG)
• intraocular pressure (IOP)
• slit lamp biomicroscopy
• optokinetic tracking (OKT)
• pachymetry
• ocular histology
• digital image analysis
Powered Research performs these complementary assessments in-house, allowing sponsors to correlate structural changes with functional outcomes and tissue-level pathology within a unified dataset.
6. Why Is Ocular Drug Delivery Expertise Important in Preclinical Studies?
Drug administration is often one of the greatest technical challenges in ophthalmology studies. Variability in injection location, delivered volume, or surgical technique can substantially influence efficacy and safety outcomes.
Powered Research routinely performs a broad range of ocular administration techniques, including intravitreal, subretinal, suprachoroidal, intracameral, subconjunctival, periocular, and topical delivery across multiple animal species. This technical expertise helps reduce procedural variability and improve study reproducibility.
7. How Can a Preclinical Ophthalmology CRO Accelerate Drug Development?
Rapid execution is valuable only when combined with rigorous experimental design and reliable data generation.
Powered Research emphasizes efficient study startup through established protocols, experienced scientific staff, flexible study design, and in-house capabilities that eliminate many delays associated with outsourcing individual study components. Because experimental activities are coordinated within a single facility, sponsors can often move from study design to final report more efficiently while maintaining high scientific standards.
8. What Qualifications Should I Look for in an Ophthalmology CRO?
Beyond equipment and animal models, scientific expertise is often the strongest predictor of study success.
Sponsors should evaluate whether the CRO has experienced study directors, veterinary ophthalmology expertise, personnel familiar with ophthalmic surgery and imaging, and a proven history of supporting ophthalmic drug development.
Powered Research's multidisciplinary team includes scientists, veterinarians, and technical specialists with extensive experience in ophthalmology research, including leadership in study design, model development, and ocular endpoint evaluation. The company has supported thousands of preclinical studies and incorporates board-certified veterinary ophthalmology expertise into its ophthalmology programs.
9. Which Animal Species Are Used in Preclinical Ophthalmology Research?
Species selection depends on the biology of the disease, therapeutic modality, ocular anatomy, and translational objectives.
Powered Research supports ophthalmology studies in rodents, rabbits, swine, and additional large-animal species when appropriate. Integrated breeding, housing, and colony management provide flexibility for both standard and customized study designs while supporting efficient scheduling.
10. What Should I Expect from a Long-Term Ophthalmology CRO Partner?
The most effective CRO relationships extend beyond executing study protocols.
Experienced scientific partners contribute to study design, endpoint selection, model optimization, interpretation of complex datasets, and strategic planning for subsequent development stages.
Powered Research works collaboratively with sponsors—from emerging biotechs to large pharmaceutical companies—to tailor study designs around specific development objectives rather than relying solely on standard protocols.
This collaborative approach, combined with integrated capabilities, rapid turnaround, and a high rate of repeat business from sponsors, helps accelerate ophthalmology programs while reducing development risk.